توقعات سوق التشخيص الجزيئي في الشرق الأوسط وأفريقيا حتى عام 2028 - تأثير فيروس كورونا (COVID-19) والتحليل الإقليمي حسب المنتجات والخدمات (المقايسات والأطقم والأدوات والخدمات والبرمجيات)، والتكنولوجيا (PCR، تكنولوجيا تضخيم الحمض النووي متساوي الحرارة ( INAAT)، وغيرها من التقنيات)، التطبيق (الأمراض المعدية، الأورام، أمراض الدم، اختبارات ما قبل الولادة، الغدد الصماء، وغيرها من التطبيقات)، المستخدم النهائي (المستشفيات والعيادات، مختبرات التشخيص، المعاهد البحثية والأكاديمية، وغيرها)

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Point-of-Care Molecular Diagnostics Market – By Product & Services

1.3.2        Middle East & Africa Point-of-Care Molecular Diagnostics Market – By Technology

1.3.3        Middle East & Africa Point-of-Care Molecular Diagnostics Market – By Application

1.3.4        Middle East & Africa Point-of-Care Molecular Diagnostics Market – By End User

1.3.5        Middle East & Africa Point-of-Care Molecular Diagnostics Market– By Geography

2.           Middle East & Africa Point-of-Care Molecular Diagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Point-of-Care Molecular Diagnostics Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East & Africa – PEST Analysis

4.3         Experts Opinion

5.           Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control

5.1.2        Rising Incidences of Infectious Diseases

5.2         Market Restraints

5.2.1        Pricing Pressures owing to Reimbursement Cuts

5.3         Market Opportunities

5.3.1        Rising R&D and Innovation in Point-of-Care Molecular Diagnostics

5.4         Future Trends

5.4.1        Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting

5.5         Impact Analysis

6.           Point-of-Care Molecular Diagnostics Market– Middle East & Africa Analysis

6.1         Middle East & Africa Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis

7.           Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services

7.1         Overview

7.2         Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

7.3         Assays and Kits

7.3.1        Overview

7.3.2        Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Instruments

7.4.1        Overview

7.4.2        Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Services and Software

7.5.1        Overview

7.5.2        Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology

8.1         Overview

8.2         Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

8.3         PCR

8.3.1        Overview

8.3.2        PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1        Overview

8.4.2        Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Point-of-Care Molecular Diagnostics Market Analysis – By Application

9.1         Overview

9.2         Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

9.3         Infectious Disease

9.3.1        Overview

9.3.2        Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Oncology

9.4.1        Overview

9.4.2        Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Hematology

9.5.1        Overview

9.5.2        Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Prenatal Testing

9.6.1        Overview

9.6.2        Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.7         Endocrinology

9.7.1        Overview

9.7.2        Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.8         Others

9.8.1        Overview

9.8.2        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User

10.1      Overview

10.2      Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

10.3      Hospitals and Clinics

10.3.1     Overview

10.3.2     Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Diagnostic Laboratories

10.4.1     Overview

10.4.2     Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Research and Academic Institutes

10.5.1     Overview

10.5.2     Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.        Middle East & Africa Point-of-Care Molecular Diagnostics Market – Geographic Analysis

11.1      Middle East & Africa: Point-of-Care Molecular Diagnostics Market

11.1.1     Overview

11.1.2     Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.3     Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)

11.1.4     Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)

11.1.5     Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)

11.1.6     Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)

11.1.7     Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

11.1.7.1       Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.1       Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.2       Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.1.3       Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.1.4       Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.1.5       Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.2       South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.1       South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.2       South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.2.3       South Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.2.4       South Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.2.5       South Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.3       UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.1       UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.2       UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.3.3       UAE: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.3.4       UAE: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.3.5       UAE: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

11.1.7.4       Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.1       Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.2       Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

11.1.7.4.3       Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

11.1.7.4.4       Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

11.1.7.4.5       Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

12.        Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market

12.1      Middle East & Africa: Impact Assessment of COVID-19 Pandemic

13.        Point-of-Care Molecular Diagnostics Market– Industry Landscape

13.1      Overview

13.2      Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

13.3      Organic Growth Strategies

13.3.1     Overview

13.4      Inorganic Growth Strategies

13.4.1     Overview

14.        Company Profiles

14.1      F. Hoffmann-La Roche Ltd.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      bioMérieux SA

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Abbott

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      MERIDIAN BIOSCIENCE, INC.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Enzo Biochem Inc.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Biocartis

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Quidel Corporation

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Danaher

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      BIO-RAD LABORATORIES INC.

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 2.             Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 3.             Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 4.             Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 5.             Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 6.             Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 7.             Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 9.             South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 10.          South Africa: Point-of-Care Molecular Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)

Table 11.          South Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 12.          South Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 13.          UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 14.          UAE: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 15.          UAE: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 16.          UAE: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

Table 20.          Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

Table 21.          Recent Organic Developments the Point-of-Care Molecular Diagnostics Market

Table 22.          Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market

Table 23.          Glossary of Terms, Point-of-Care Molecular Diagnostics Market

LIST OF FIGURES

Figure 1.           Point-of-Care Molecular Diagnostics Market Segmentation

Figure 2.           Middle East & Africa Point-of-Care Molecular Diagnostics Market Overview

Figure 3.           Assays and Kits Segment Held the Largest Share by Product & services in Middle East & Africa Point-of-Care Molecular Diagnostics Market

Figure 4.           South Africa to Show Significant Growth During Forecast Period

Figure 5.           Middle East & Africa Point-of-Care Molecular Diagnostics Market, Industry Landscape

Figure 6.           Middle East & Africa PEST Analysis

Figure 7.           Middle East & Africa Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8.           Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

Figure 9.           Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.        Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

Figure 13.        PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

Figure 17.        Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

Figure 24.        Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Middle East & Africa: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)

Figure 29.        Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

Figure 31.        Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 32.        South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 33.        UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Middle East & Africa

Figure 36.        Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

1. bioMérieux SA
2. F. Hoffmann-La Roche Ltd.
3. Danaher Corporation
4. Enzo Biochem, Inc.
5. Abbott
6. Meridian BioScience, Inc.
7. Biocartis
8. Quidel Corporation
9. Bio-Rad Laboratories, Inc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Point-of-Care molecular diagnostics market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.